Changing Therapies in Type 2 Diabetes
List Price:
$73.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
R.D.G. Leslie, Paolo Pozzilli
Format:
Paperback
Pages:
118
Publisher:
CRC Press (April 25, 2002)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9781841841113
ISBN-10:
1841841110
Weight:
7.875oz
Dimensions:
5.5" x 8.25"
File:
TAYLORFRANCIS-TayFran_260729050012228-20260729.xml
Folder:
TAYLORFRANCIS
List Price:
$73.99
Country of Origin:
United States
Case Pack:
75
As low as:
$70.29
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Imprint:
CRC Press
Overview
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
